Natera, Inc. (NTRA) stock analysis
In our weekly check, Natera, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 10 pass, warnings: 5, red flags: 7.
About Natera, Inc.
Natera, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as NTRA.
What our checks show for NTRA
Red flags
- The company has an operating loss, so it does not cover the interest bill: interest is paid from cash or new debt.
- Earnings per share fell 41.1% a year over the last 3 years.
- The company is losing money: the net margin is -5.7%.
- The price swings a lot: 51.8% annual volatility. Expect large ups and downs.
- The stock has fallen as much as 78% from a peak. Would you have held through that?
- Return on capital (ROCE) is zero or negative: the business does not earn on the money put into it.
- Pay in shares equals 757% of free cash flow: it dilutes shareholders.
Warning signs
- Analysts expect earnings per share to shrink about 3.5% a year.
- Free cash flow is only 1.8% of revenue.
- Recovering from its deepest fall took about 2.3 years.
- Beta 1.53: the stock usually moves more than the market, both up and down.
- The share count grew by 18.9% in 2 years: each shareholder owns a smaller slice.
Strengths
- Debt is low: 0.13x equity.
- The net margin rose by 69.8 points over 5 years, to -5.7%.
- The gross margin is 65.2% and has risen by 16.1 points: pricing power is holding.
- Operating cash flow is 1.29x net profit: the profit arrives as real cash.
- Analysts expect revenue to grow about 21.1% a year over the next years.
- Analysts expect the net margin to improve by 10.6 points from today's -5.7%.
Similar companies
WAT · IQV · A · IDXX · MTD · ILMN
Questions
What grade does Natera, Inc. (NTRA) have?
In our weekly check, Natera, Inc. is graded C (A to F). Of 22 checks on debt, profit, cash flow and trend: 10 pass, warnings: 5, red flags: 7. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of NTRA stock?
This week's biggest flags for Natera, Inc.: Weak interest cover, Weak EPS growth, Thin margins. In total 12 of 22 checks show a warning or a red flag.
What does Natera, Inc. do?
Natera, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NASDAQ as NTRA.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis